Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer
Abstract Pancreatic cancer (PC) is a growing global burden, remaining one of the most lethal cancers of the gastrointestinal tract. Moreover, PC is resistant to various treatments such as chemotherapy, radiotherapy, and immunotherapy. New therapies are urgently needed to improve the prognosis of PC....
Main Authors: | Wenhao Luo, Yawen Wang, Taiping Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-04-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-022-02583-1 |
Similar Items
-
Oncolytic viruses and pancreatic cancer
by: Vahideh Hamidi-Sofiani, et al.
Published: (2022-01-01) -
Current landscape and perspective of oncolytic viruses and their combination therapies
by: Yinghan Su, et al.
Published: (2022-11-01) -
Recent progress in combination therapy of oncolytic vaccinia virus
by: Seyedeh Nasim Mirbahari, et al.
Published: (2024-03-01) -
The Present Status of Immuno-Oncolytic Viruses in the Treatment of Pancreatic Cancer
by: Scott D. Haller, et al.
Published: (2020-11-01) -
Oncolytic Viral Therapy for Mesothelioma
by: Daniel F. Pease, et al.
Published: (2017-08-01)